Author/Authors :
Mohammadzadeh, Alireza Department of Microbiology - School of Medicine - Gonabad University of Medical Sciences, Gonabad , Mardaneh, Jalal Department of Microbiology - School of Medicine - Gonabad University of Medical Sciences, Gonabad , Ahmadi, Reza Department of Internal Medicine - School of Medicine - Gonabad University of Medical Sciences, Gonabad , Adabi, Javad Microbiology Laboratory - 22Bahman Hospital - Gonabad University of Medical Sciences, Gonabad
Abstract :
Background: Pseudomonas aeruginosa is a ubiquitous microorganism, which is present in diverse environmental niches and is
seldom a member of normal human microbiota community. P. aeruginosa is an increasingly problematic drug-resistant bacterium
in today’s world. In fact, we are now faced with growing clones of pandrug-resistant P. aeruginosa in hospital settings.
Objectives: The aim of the present study was to examine the antibiotic resistance patterns and presence of nan1 and int1 virulence
genes (encoding neuraminidase and class 1 integrons, respectively) in clinical P. aeruginosa isolates and to analyze the measured
values with regard to hospital wards, specimens, and antibiotic resistance of the strains.
Methods: In this cross sectional study, strains recovered consecutively from different samples of hospitalized patients between
2014 and 2016 in Gonabad, Iran, were tested. Culture of specimens was performed on common bacteriological culture media. The
isolates were recognized as P. aeroginosa, based on morphological and biochemical tests. The isolates, identified as presumptive P.
aeruginosa, were further confirmed by species-specific polymerase chain reaction (PCR) to detect exoA gene. All the isolates were
tested for their antimicrobial susceptibility patterns, using the standard guidelines issued by the clinical and laboratory standards
institute (CLSI). Genes encoding the virulence factors (nan1 and int1) were investigated by PCR using specific primers.
Results: Overall, 95 P. aeruginosa isolates were studied during the study period. The isolates were recovered from 30 (31.6%) males
and 65 (68.4%) females. In total, 34 (35.5%) infected patients were in the age group of 30 - 44 years. There were 24 (25.3%) patients
hospitalized in the intensive care unit (ICU). A total of 31 (32.6%) strains were isolated from the blood. Colistin was the most effective
antibiotic against the isolates, and ticarcillin was the least effective antimicrobial agent. Based on the findings, 21.1% of the P. aeroginosa
strains were resistant to the quinolone class of antimicrobial agents. Also, ceftazidime resistance was detected in the isolates
(10.5%). Based on the results, 5.26% of the tested isolates were co-resistant to ceftazidime, amikacin, and piperacillin/tazobactam.
Among 95 P. aeroginosa isolates on which PCR assay was performed, 44.2% had the nan1 gene.
Conclusions: Selection of the most effective anti-Pseudomonal drug (including in vitro test and report) is a decision best made
by each clinical microbiology laboratory in consultation with the infectious diseases practitioners and pharmacologists, as well as
therapeutic and hospital infection control committees. The guidelines for each bacterium include antibiotics of confirmed effectiveness,
which show acceptable results in antibiotic susceptibility tests.
Keywords :
Hospital , Virulence Factors , Antibiotic Resistance , Pseudomonas aeroginosa